Together, we show that the RBP Dnd1 prohibits miRNA-dependent inhibition of Bim expression in breast cancer cells and underscores the tumor-inhibitory roles of the Dnd1 in breast cancer apoptosis, so it may be a possible therapeutic target of breast cancer. This evidence concerns the gene BCL2L11 and breast cancer.